This report provides exclusive insights into the COVID-19 impact on the Exosomes Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Exosomes Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Exosomes Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.
report published by Infinium Global Research on exosomes market provides
in-depth analysis of segments and sub-segments in the global as well as
regional exosomes market. The study also highlights the impact of drivers,
restraints, and macro indicators on the global and regional exosomes market
over the short term as well as long term. The report is a comprehensive
presentation of trends, forecast and dollar values of global exosomes market.
According to the report, the global exosomes market is projected to grow at a
CAGR of 17.5% over the forecast period of 2019-2025.
Exosomes are extracellular vesicles that are made of the phospholipid
bilayer. They are enclosed vesicles from eukaryotic cells. Exosomes are
secreted by almost all cell types, they are found in urine, saliva, serum,
plasma, amniotic fluid, and other biological fluids. They act as messengers
between the cells conveying a message to the distant cells. Exosomes carry
nucleic acids, protein, and lipids from cell to cell. Exosomes are unique in
nature and it has a wide variety of functions, the most interesting function of
exosome is cell communication and cell signaling. Exosomes have adaptive immune
responses to tumors and pathogens. Exosomes are used for diagnosis of diseases
like cancer, neurodegenerative disorders, and other human pathological
The growing adoption of exosomes in production of biomarkers, therapeutics
and non-invasive diagnostics since the last five years is heading the
development of exosomes market. Exosomes are quantified in human plasma and
other biological fluids for the diagnosis of malignant and benign tumors.
Furthermore, there is a surge of innovation with respect to the unexplored area
of exosomes in research and development. The rapid growth of cancer and
neurodegenerative disease and the use of exosomes in the diagnosis of cancer is
contributing to the growth of exosomes in the diagnostics and therapeutics
segment. It allows the detection and monitoring of disorder at an early stage.
However, the major restraint for the growth of exosomes is the lack of skilled
professionals and the high cost of therapies. Moreover, due to growing
awareness about exosomes for disease diagnosis and the rising technological
advancements in biomarkers are projected to create growth opportunities for the
exosomes market over the forecast period.
Amongst to geographies, North America has the maximum share in the
exosomes market. The major factors contributing to the growth of this region
are high occurrences of cancer and an increasing number of clinical trials in
countries such as the U.S. and Canada. Europe holds the second position owing
to technical advances in healthcare. The Asia Pacific is the fastest-growing
region. The increased rate of neurodegenerative diseases, resulting in
increased diagnosis and the rising investments in research and development from
several established healthcare companies are the factors contributing to the
growth of the Asia Pacific exosome market.
The report on
global exosomes market covers segments such as applications, and end-user. On
the basis of applications, the sub-markets include neurodegenerative diseases,
oncology, cardiovascular diseases, infectious diseases, and genetic disorders.
On the basis of end-user, the sub-markets include hospitals, diagnostic
centers, cancer institutes, and research laboratories.
provides profiles of the companies in the market such as Bio-Techne
Corporation, Takara Bio Company, Codiak BioSciences Inc., Evox Therapeutics
Limited, ExCoBio Inc., ArunA Bio, Inc. Kimera Society Inc., Aegle Therapeutics
Corporation and Anjarium Biosciences AG.
provides deep insights into the demand forecasts, market trends, and micro and
macro indicators. In addition, this report provides insights into the factors
that are driving and restraining the growth in this market. Moreover, The
IGR-Growth Matrix analysis given in the report brings an insight into the
investment areas that existing or new market players can consider. The report
provides insights into the market using analytical tools such as Porter's five
forces analysis and DRO analysis of exosomes market. Moreover, the study
highlights current market trends and provides forecast from 2019-2025. We also
have highlighted future trends in the market that will affect the demand during
the forecast period. Moreover, the competitive analysis given in each regional
market brings an insight into the market share of the leading players.